Work

ABCL-289: Matching-Adjusted Indirect Comparison (MAIC) of Axicabtagene Ciloleucel (Axi-Cel) and Lisocabtagene Maraleucel (Liso-Cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) After Two or More Prior Lines of Therapy

Year: 2021

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(21)01882-6

Authors: Olalekan O Oluwole, Jenny MH Chen, Keith Chan, Anik R Patel, Jeroen P Jansen, Sam Keeping, Zahid Bashir, Yan Zheng, Julia Snider, Frederick L Locke

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Kite (United States), Moffitt Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3197318668

FWCI: 0.246

Cites:

Cited by: 3

Related to: 10